T&R Biofab Co., Ltd. (KOSDAQ:246710)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,866.00
-84.00 (-4.31%)
Oct 30, 2025, 3:30 PM KST
-4.31%
Market Cap48.25B
Revenue (ttm)14.82B
Net Income (ttm)-8.66B
Shares Out25.86M
EPS (ttm)-2,008.73
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume286,313
Average Volume549,323
Open1,950.00
Previous Close1,950.00
Day's Range1,840.00 - 1,950.00
52-Week Range1,775.00 - 7,430.00
Beta0.68
RSI40.19
Earnings DateNov 21, 2025

About T&R Biofab

T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea. [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 2013
Employees 86
Stock Exchange KOSDAQ
Ticker Symbol 246710
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.